Pancreatic Cancer Research

ResearcherHospital Clínic de BarcelonaActive in the last 2 years

Fabio Ausania

Matched on ORCID iD 0000-0001-8891-2546; OpenAlex author ID A5033883250, A5050540975. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
60
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 4 papers · 2024: 3 papers · 2025: 4 papers · 2026: 2 papers

Papers 14

  1. Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study. Co-author DOI 10.1016/j.cireng.2026.800304↗
  2. Robotic Distal Splenopancreatectomy and Left Nephrectomy: Double Docking for En Bloc Resection of Pancreatic Cancer. Last author DOI 10.1245/s10434-026-19597-y↗
  3. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  4. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: an international multicentre retrospectiv… Co-author DOI 10.1016/j.hpb.2024.11.015↗
  5. Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors. Co-author DOI 10.1016/j.semcancer.2025.06.001↗
  6. Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whi… Co-author DOI 10.3390/cancers17071223↗
  7. Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After W… Co-author DOI 10.1016/j.hpb.2024.04.010↗
  8. Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells an… Co-author DOI 10.1093/bjsopen/zrae123↗
  9. Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Co-author DOI 10.3390/cancers16223779↗
  10. Robotic versus laparoscopic distal pancreatectomy for pancreatic adenocarcinoma in obese patients. Co-author DOI 10.1002/rcs.2596↗
  11. Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentr… Co-author DOI 10.14701/ahbps.23-042↗
  12. Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. Co-author DOI 10.3389/fmolb.2023.1161893↗
  13. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. Co-author DOI 10.3390/cancers15061690↗
  14. Retrospective studies and pancreatic adenocarcinoma: how far can we backdate? Co-author DOI 10.1097/sla.0000000000000416↗

Closest collaborators

The 25 strongest of 60 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carolina González Abós · 2 shared papers, 2023–2026 · strength 0.56
  2. Elizabeth Pando Rau · 3 shared papers, 2023–2026 · strength 0.52
  3. Gregorio Di Franco · 2 shared papers, 2023–2025 · strength 0.34
  4. Luca Morelli · 2 shared papers, 2023–2025 · strength 0.34
  5. Joan Llach · 2 shared papers, 2023–2024 · strength 0.31
  6. Leticia Moreira · 2 shared papers, 2023–2024 · strength 0.31
  7. Glòria Fernández‐Esparrach · 2 shared papers, 2023 · strength 0.30
  8. Àngels Ginés Gibert · 2 shared papers, 2023 · strength 0.30
  9. Eva Cristina Vaquero · 2 shared papers, 2023 · strength 0.30
  10. Duncan R.C. Spalding · 2 shared papers, 2023–2025 · strength 0.28
  11. Alberto Porcu · 2 shared papers, 2023–2025 · strength 0.28
  12. Thomas Brendon Russell · 2 shared papers, 2023–2025 · strength 0.28
  13. Ricky Harminder Bhogal · 2 shared papers, 2023–2025 · strength 0.28
  14. Somaiah Aroori · 2 shared papers, 2023–2025 · strength 0.28
  15. Ismael Domínguez-Rosado · 2 shared papers, 2023–2025 · strength 0.28
  16. Dhanny Gomez · 2 shared papers, 2023–2025 · strength 0.28
  17. Brian Ritchie Davidson · 2 shared papers, 2023–2025 · strength 0.28
  18. Manuel Maglione · 2 shared papers, 2023–2025 · strength 0.28
  19. Keith John Roberts · 2 shared papers, 2023–2025 · strength 0.28
  20. Peter Lawrence Zaki Labib · 2 shared papers, 2023–2025 · strength 0.28
  21. Andrew Malvern Smith · 2 shared papers, 2023–2025 · strength 0.28
  22. Zaed Z. R. Hamady · 2 shared papers, 2023–2025 · strength 0.28
  23. Daniel Gerald Croagh · 2 shared papers, 2023–2025 · strength 0.28
  24. Adam Enver Frampton · 2 shared papers, 2023–2025 · strength 0.28
  25. Laura Guarga · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.